|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn606519270 |
003 |
OCoLC |
005 |
20231117033044.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100411s2000 enka ob 101 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d NLGGC
|d OCLCQ
|d N$T
|d OPELS
|d OCLCF
|d OCLCO
|d YDXCP
|d EBLCP
|d MHW
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d D6H
|d CHVBK
|d OCLCQ
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 609337278
|a 839580690
|a 871225219
|a 906265199
|
020 |
|
|
|a 1845698185
|q (electronic bk.)
|
020 |
|
|
|a 9781845698188
|q (electronic bk.)
|
020 |
|
|
|z 1855737779
|
020 |
|
|
|z 9781855737778
|
020 |
|
|
|z 0854048154
|
020 |
|
|
|z 9780854048151
|
035 |
|
|
|a (OCoLC)606519270
|z (OCoLC)609337278
|z (OCoLC)839580690
|z (OCoLC)871225219
|z (OCoLC)906265199
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QH468
|b .D54 2000
|
060 |
|
4 |
|a 2001 J-212
|
060 |
|
4 |
|a QZ 266
|b D5651 2000
|
070 |
|
4 |
|a QH468
|b .D54 2000
|
072 |
|
0 |
|a T300
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.994052
|2 21
|
245 |
0 |
0 |
|a Dietary anticarcinogens and antimutagens :
|b chemical and biological aspects /
|c edited by I.T. Johnson and G.R. Fenwick.
|
260 |
|
|
|a Cambridge :
|b Royal Society of Chemistry,
|c �2000.
|
300 |
|
|
|a 1 online resource (xiv, 438 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Special publication ;
|v no. 255
|
504 |
|
|
|a Includes bibliographical references and index.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a Comprehensive and international in content, Dietary anticarcinogens and antimutagens: Chemical and biological aspects includes topics as diverse as the health benefits of tea, wine and beer, through the prevention of various cancers, to the development of effective communication for healthy eating. The book is organised in to sections covering: epidemiology of diet and cancer; mechanisms of DNA damage and repair; the body's various protective mechanisms; and experimental approaches to the study of diet and cancer, with particular emphasis on humans as subjects.
|
505 |
0 |
|
|a Front Cover; Dietary Anticarcinogens and Antimutagens: Chemical and Biological Aspects; Copyright Page; Preface; Table of Contents; Section 1: Anticarcinogens and Mutagens in the Human Diet: Epidemiology; Chapter 1.1 Colorectal Neoplasia and Meat: Epidemiology and Mechanisms; 1 Introduction; 2 The Epidemiologic Data; 3 Mechanisms; 4 Summary; 5 References; Chapter 1.2. Green Tea as a Cancer Preventive; 1 Abstract; 2 Introduction; 3 Cancer Chemoprevention; 4 Anticarcinogenic Effects and Other Preventive Activities; 5 Bioavailability of Tea Polyphenols; 6 Epidemiological Studies.
|
505 |
8 |
|
|a 7 Two Stages of Cancer Prevention with Green Tea8 Summary; 9 References; Chapter 1.3 Dietary Fibre and Resistant Starch -- Do They Protect against Cancer?; 1 Introduction; 2 RS, Soluble DF and Cancer; 3 Insoluble DF and Cancer; 4 Conclusions; 5 References; Chapter 1.4 Antioxidant Catechins: Intake and Major Sources in the Dutch Population; 1 Introduction; 2 Catechin Content of Foods; 3 National Food Consumption Survey; 4 Conclusions; 5 References; Chapter 1.5. Intake of Selected Vitamins and Bioflavonoids from Vitamin and Mineral Supplements by Subjects in the EPIC- NORFOLK Study, UK.
|
505 |
8 |
|
|a 1 Ecological Factors of the Colon Related to Tumour Growth2 Risk Factors of Colon Cancer and Relation to Colon Heat; 3 References; Section 2: Bioavailability of Dietary Anticarcinogens and Mutagens; Chapter 2.1 Bioavailabilities of Bioactive Components in the Human Diet; 1 From Epidemiology to Experiment: A Leap of Faith; 2 Determining Bioavailability is Essential to Progress; 3 Experimental Approaches; 4 References; Chapter 2.2 The First Step in the Metabolism of Flavonoid Glycosides; References.
|
505 |
8 |
|
|a Chapter 2.3 Kinetic Models Describing In vitro Transport and Metabolism of Isoflavones and Their Glycosides in Human Caco-2 Cells1 Introduction; 2 Materials and Method; 3 Results; 4 Discussion; 5 References; Chapter 2.4 Transport and Metabolism of Genistein, Daidzein and Their Glycosides in Caco-2 Cells and in Perfused Gut Segments; 1 Introduction; 2 Materials and Method; 3 Results; 4 Discussion; 5 References; Chapter 2.5 Stability of Flavonol Glycosides During Digestion and Evidence for Interaction with the Sodium Dependent Glucose/Galactose Transport Pathway; 1 Introduction; 2 Methods.
|
650 |
|
0 |
|a Antimutagens
|v Congresses.
|
650 |
|
0 |
|a Cancer
|x Prevention
|v Congresses.
|
650 |
|
0 |
|a Cancer
|x Diet therapy
|v Congresses.
|
650 |
|
0 |
|a Antineoplastic agents
|v Congresses.
|
650 |
|
0 |
|a Cancer
|x Nutritional aspects
|v Congresses.
|
650 |
|
0 |
|a Antimutagens.
|
650 |
|
0 |
|a Diet therapy.
|
650 |
1 |
2 |
|a Neoplasms
|x therapy
|0 (DNLM)D009369Q000628
|
650 |
2 |
2 |
|a Anticarcinogenic Agents
|0 (DNLM)D016588
|
650 |
2 |
2 |
|a Antimutagenic Agents
|0 (DNLM)D016587
|
650 |
2 |
2 |
|a Diet Therapy
|0 (DNLM)D004035
|
650 |
2 |
2 |
|a Neoplasms
|x prevention & control
|0 (DNLM)D009369Q000517
|
650 |
|
6 |
|a Antimutag�enes
|0 (CaQQLa)201-0047977
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Cancer
|0 (CaQQLa)201-0032223
|x Pr�evention
|0 (CaQQLa)201-0032223
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Cancer
|0 (CaQQLa)201-0086476
|x Di�etoth�erapie
|0 (CaQQLa)201-0086476
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Anticanc�ereux
|0 (CaQQLa)201-0004692
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Cancer
|0 (CaQQLa)201-0004689
|x Aspect nutritionnel
|0 (CaQQLa)201-0004689
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Antimutag�enes.
|0 (CaQQLa)201-0047977
|
650 |
|
6 |
|a Di�etoth�erapie.
|0 (CaQQLa)201-0069190
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Diet therapy
|2 fast
|0 (OCoLC)fst00893321
|
650 |
|
7 |
|a Antimutagens
|2 fast
|0 (OCoLC)fst00810594
|
650 |
|
7 |
|a Antineoplastic agents
|2 fast
|0 (OCoLC)fst00810595
|
650 |
|
7 |
|a Cancer
|x Diet therapy
|2 fast
|0 (OCoLC)fst00845350
|
650 |
|
7 |
|a Cancer
|x Nutritional aspects
|2 fast
|0 (OCoLC)fst00845407
|
650 |
|
7 |
|a Cancer
|x Prevention
|2 fast
|0 (OCoLC)fst00845452
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Johnson, I. T.
|
700 |
1 |
|
|a Fenwick, G. R.
|
776 |
0 |
8 |
|i Print version:
|t Dietary anticarcinogens and antimutagens.
|d Cambridge : Royal Society of Chemistry, �2000
|w (OCoLC)45314757
|
830 |
|
0 |
|a Special publication (Royal Society of Chemistry (Great Britain)) ;
|v no. 255.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9781855737778
|z Texto completo
|